References
- Adlercreutz H (1995). Phytoestrogens: epidemiology and a possible role in cancer protection. Environ Health Perspect, 103, 103-12. https://doi.org/10.1289/ehp.95103s2103
- Bahadoran Z, Karimi Z, Houshiar-rad A, et al (2013). Dietary phytochemical index and the risk of breast cancer: a case control study in a population of Iranian women. Asian Pac J Cancer Prev, 14, 2747-51. https://doi.org/10.7314/APJCP.2013.14.5.2747
- Balunas MJ, Kinghorn AD (2010). Natural compounds with aromatase inhibitory activity: an update. Planta Med, 76, 1087-93. https://doi.org/10.1055/s-0030-1250169
- Behan LA, Amir E, Casper RF (2015). Aromatase inhibitors for prevention of breast cancer in postmenopausal women: a narrative review. Menopause, 22, 342-50. https://doi.org/10.1097/GME.0000000000000426
- Bernstein L, Ross RK (1993). Endogenous hormones and breast cancer risk. Epidemiol Rev, 15, 48-65.
- Brueggemeier RW, Hackett JC, Diaz-Cruz ES (2005). Aromatase inhibitors in the treatment of breast cancer. Endocr Rev, 26, 331-45. https://doi.org/10.1210/er.2004-0015
- Bulun SE, Sebastian S, Takayama K, et al (2003). The human CYP19 (aromatase P450) gene: update on physiologic roles and genomic organization of promoters. J Steroid Biochem Mol Biol, 86, 219-24. https://doi.org/10.1016/S0960-0760(03)00359-5
- Cazzaniga M, Bonanni B (2012). Breast cancer chemoprevention: old and new approaches. J Biomed Biotechnol, 2012, 985620.
- Chen S, Oh SR, Phung S, et al (2006). Anti-aromatase activity of phytochemicals in white button mushrooms (Agaricus bisporus). Cancer Res, 66, 12026-34. https://doi.org/10.1158/0008-5472.CAN-06-2206
- Chumsri S, Howes T, Bao T, et al (2011). Aromatase, aromatase inhibitors, and breast cancer. J Steroid Biochem Mol Biol, 125, 13-22. https://doi.org/10.1016/j.jsbmb.2011.02.001
- Cieza A, Maier P, Poppel E (2003). Effects of Ginkgo biloba on mental functioning in healthy volunteers. Arch of Med Res, 34, 373-81. https://doi.org/10.1016/j.arcmed.2003.05.001
- Dubber MJ, Kanfer I (2004). High-performance liquid chromatographic determination of selected flavonols in Ginkgo biloba solid oral dosage forms. J Pharm Pharm Sci, 7, 303-9.
- Eng ET, Ye J, Williams D, et al (2003). Suppression of estrogen biosynthesis by procyanidin dimers in red wine and grape seeds. Cancer Res, 63, 8516-22.
- Harada N, Utsumi T, Takagi Y (1993). Tissue-specific expression of the human aromatase cytochrome P-450 gene by alternative use of multiple exons 1 and promoters, and switching of tissue-specific exons 1 in carcinogenesis. Proc Natl Acad Sci U S A, 90, 11312-6. https://doi.org/10.1073/pnas.90.23.11312
- Hong Y, Chen S (2006). Aromatase inhibitors: structural features and biochemical characterization. Ann N Y Acad Sci, 1089, 237-51. https://doi.org/10.1196/annals.1386.022
- Huang SM, Temple R, Throckmorton DC, et al (2007). Drug interaction studies: study design, data analysis, and implications for dosing and labeling. Clin Pharmacol Ther, 81, 298-304. https://doi.org/10.1038/sj.clpt.6100054
- Iwase H, Yamamoto Y (2015). Clinical benefit of sequential use of endocrine therapies for metastatic breast cancer. Int J Clin Oncol, 20, 253-61. https://doi.org/10.1007/s10147-015-0793-8
- Kamat A, Alcorn JL, Kunczt C, et al (1998). Characterization of the regulatory regions of the human aromatase (P450arom) gene involved in placenta-specific expression. Mol Endocrinol, 12, 1764-77. https://doi.org/10.1210/mend.12.11.0190
- Kellis JT, Jr., Vickery LE (1984). Inhibition of human estrogen synthetase (aromatase) by flavones. Science, 225, 1032-4. https://doi.org/10.1126/science.6474163
- Khan SI, Zhao J, Khan IA, et al (2011). Potential utility of natural products as regulators of breast cancer-associated aromatase promoters. Reprod Biol Endocrinol, 9, 91. https://doi.org/10.1186/1477-7827-9-91
- Kijima I, Phung S, Hur G, et al (2006). Grape seed extract is an aromatase inhibitor and a suppressor of aromatase expression. Cancer Res, 66, 5960-7. https://doi.org/10.1158/0008-5472.CAN-06-0053
- Kim MJ, Park YJ, Chung KH, et al (2013). The inhibitory effects of the standardized extracts of ginkgo biloba on aromatase activity in JEG-3 human choriocarcinoma cells. phytother res.
- Kleijnen J, Knipschild P (1992). Ginkgo biloba. Lancet, 340, 1136-9. https://doi.org/10.1016/0140-6736(92)93158-J
- Kohler PO, Bridson WE (1971). Isolation of hormoneproducing clonal lines of human choriocarcinoma. J Clin Endocrinol Metab, 32, 683-7. https://doi.org/10.1210/jcem-32-5-683
- Kudolo GB (2001). The effect of 3-month ingestion of Ginkgo biloba extract (EGb 761) on pancreatic beta-cell function in response to glucose loading in individuals with non-insulin-dependent diabetes mellitus. J Clin Pharmacol, 41, 600-11. https://doi.org/10.1177/00912700122010483
- Kudolo GB, Delaney DJ (2001). The effect of the ingestion of Ginkgo biloba extract on platelet lipid peroxidation. Clin Chem, 47, 51.
- Lu DF, Yang LJ, Wang F, et al (2012). Inhibitory effect of luteolin on estrogen biosynthesis in human ovarian granulosa cells by suppression of aromatase (CYP19). J Agric Food Chem, 60, 8411-8. https://doi.org/10.1021/jf3022817
- Mahmoud F, Abul H, Onadeko B, et al (2000). In vitro effects of Ginkgolide B on lymphocyte activation in atopic asthma: Comparison with cyclosporin A. Japanese J Pharmacol, 83, 241-5. https://doi.org/10.1254/jjp.83.241
- Meiyanto E, Hermawan A, Anindyajati (2012). Natural products for cancer-targeted therapy: citrus flavonoids as potent chemopreventive agents. Asian Pac J Cancer Prev, 13, 427-36. https://doi.org/10.7314/APJCP.2012.13.2.427
- Monteiro R, Azevedo I, Calhau C (2006). Modulation of aromatase activity by diet polyphenolic compounds. J Agric Food Chem, 54, 3535-40. https://doi.org/10.1021/jf053237t
- Mu YM, Yanase T, Nishi Y, et al (2000). A nuclear receptor system constituted by RAR and RXR induces aromatase activity in MCF-7 human breast cancer cells. Mol Cell Endocrinol, 166, 137-45. https://doi.org/10.1016/S0303-7207(00)00273-2
- Mukhopadhyay K, Liu Z, Bandyopadhyay A, et al (2015). Aromatase Expression Increases the Survival and Malignancy of Estrogen Receptor Positive Breast Cancer Cells. PLoS One, 10, 121136.
- Oh SM, Chung KH (2004). Estrogenic activities of Ginkgo biloba extracts. Life Sci, 74, 1325-35. https://doi.org/10.1016/j.lfs.2003.06.045
- Oh SM, Chung KH (2006). Antiestrogenic activities of Ginkgo biloba extracts. J Steroid Biochem Mol Biol, 100, 167-76. https://doi.org/10.1016/j.jsbmb.2006.04.007
- Oh SM, Kim HR, Chung KH (2008). Effects of ginkgo biloba on in vitro osteoblast cells and ovariectomized rat osteoclast cells. Arch Pharm Res, 31, 216-24. https://doi.org/10.1007/s12272-001-1144-z
- Perez P, Pulgar R, Olea-Serrano F, et al (1998). The estrogenicity of bisphenol A-related diphenylalkanes with various substituents at the central carbon and the hydroxy groups. Environ Health Perspect, 106, 167-74. https://doi.org/10.1289/ehp.98106167
- Plant N (2004). Strategies for using in vitro screens in drug metabolism. Drug Discov Today, 9, 328-36. https://doi.org/10.1016/S1359-6446(03)03019-8
- Renoir JM, Marsaud V, Lazennec G (2012). Estrogen receptor signaling as a target for novel breast cancer therapeutics. Biochem Pharmacol.
- Rigney U, Kimber S, Hindmarch I (1999). The effects of acute doses of standardized Ginkgo biloba extract on memory and psychomotor performance in volunteers. Phytother Res, 13, 408-15. https://doi.org/10.1002/(SICI)1099-1573(199908/09)13:5<408::AID-PTR530>3.0.CO;2-C
- Saarinen N, Joshi SC, Ahotupa M, et al (2001). No evidence for the in vivo activity of aromataseinhibiting flavonoids. J Steroid Biochem Mol Biol, 78, 231-9. https://doi.org/10.1016/S0960-0760(01)00098-X
- Suganya J, Radha M, Naorem DL, et al (2014). In Silico docking studies of selected flavonoids--natural healing agents against breast cancer. Asian Pac J Cancer Prev, 15, 8155-9. https://doi.org/10.7314/APJCP.2014.15.19.8155
- To SQ, Knower KC, Cheung V, et al (2015). Transcriptional control of local estrogen formation by aromatase in the breast. J Steroid Biochem Mol Biol, 145, 179-86. https://doi.org/10.1016/j.jsbmb.2014.05.004
- Wang Y, Lee KW, Chan FL, et al (2006). The red wine polyphenol resveratrol displays bilevel inhibition on aromatase in breast cancer cells. Toxicol Sci, 92, 71-7. https://doi.org/10.1093/toxsci/kfj190
- Yager JD, Davidson NE (2006). Estrogen carcinogenesis in breast cancer. N Engl J Med, 354, 270-82. https://doi.org/10.1056/NEJMra050776
- Yue W, Brodie AM (1997). Mechanisms of the actions of aromatase inhibitors 4-hydroxyandrostenedione, fadrozole, and aminoglutethimide on aromatase in JEG-3 cell culture. J Steroid Biochem Mol Biol, 63, 317-28. https://doi.org/10.1016/S0960-0760(97)00072-1
Cited by
- The effects of the standardized extracts of Ginkgo biloba on steroidogenesis pathways and aromatase activity in H295R human adrenocortical carcinoma cells vol.31, pp.2233-6567, 2016, https://doi.org/10.5620/eht.e2016010
- Leaves Extract (EGb 761) by a Validated UPLC–MS-MS Method pp.1945-239X, 2017, https://doi.org/10.1093/chromsci/bmw206